Natixis Advisors LLC Trims Position in HCA Healthcare, Inc. $HCA

Natixis Advisors LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 121,250 shares of the company’s stock after selling 3,257 shares during the quarter. Natixis Advisors LLC’s holdings in HCA Healthcare were worth $56,607,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Holos Integrated Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $29,000. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $26,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $34,000. Finally, Basepoint Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $35,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on HCA shares. Stephens dropped their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Weiss Ratings cut shares of HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, May 18th. Barclays dropped their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Leerink Partners dropped their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, UBS Group lifted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $515.77.

Get Our Latest Stock Report on HCA

HCA Healthcare Stock Down 0.9%

NYSE HCA opened at $364.00 on Thursday. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The business’s fifty day simple moving average is $444.21 and its 200-day simple moving average is $478.72. The firm has a market cap of $80.75 billion, a PE ratio of 12.52, a P/E/G ratio of 1.16 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is currently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.